We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients (NNNB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01291459
Recruitment Status : Unknown
Verified December 2015 by Dr Laurent COTTE, Association Pour la Recherche en Infectiologie.
Recruitment status was:  Active, not recruiting
First Posted : February 8, 2011
Last Update Posted : December 30, 2015
Information provided by (Responsible Party):
Dr Laurent COTTE, Association Pour la Recherche en Infectiologie

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : December 2015

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 9, 2018